Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study of Alwextin® Cream in Treating Epidermolysis Bullosa: Complete Statistical AnalysisIndependent statistical analysis of Study of Alwextin® Cream in Treating Epidermolysis Bullosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00825565).
- Study of ALXN1820 in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of ALXN1820 in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631562).
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05218096).
- Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation: Complete Statistical AnalysisIndependent statistical analysis of Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of AMG 256 in Adult Subjects With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 256 in Adult Subjects With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries: Complete Statistical AnalysisIndependent statistical analysis of Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD: Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies: Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016): Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00092495).
- Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships: Complete Statistical AnalysisIndependent statistical analysis of Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02735239).
- Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD): Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).: Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD): Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Arsenic Trioxide in Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Arsenic Trioxide in Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01470248).
- Study of ASN51 in Adults With Early Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of ASN51 in Adults With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06677203).
- Study of ASTX029 in Subjects With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of ASTX029 in Subjects With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03520075).
- Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF): Complete Statistical AnalysisIndependent statistical analysis of Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139306).
- Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03120676).
- Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.: Complete Statistical AnalysisIndependent statistical analysis of Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson’s Disease Patients With Motor Fluctuations in Korea: Complete Statistical AnalysisIndependent statistical analysis of Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan: Complete Statistical AnalysisIndependent statistical analysis of Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05249569).
- Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03419897).
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic: Complete Statistical AnalysisIndependent statistical analysis of Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02118961).
- Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib: Complete Statistical AnalysisIndependent statistical analysis of Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251354).
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): Complete Statistical AnalysisIndependent statistical analysis of Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04254978).
- Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care: Complete Statistical AnalysisIndependent statistical analysis of Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…